Physician profile
James M Muse
NPI 1679652762
$7,190.15
in general payments reported to CMS, 2019-2025
45 companies · $860 in 2025
The $860 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $564 · 2021: $1,368 · 2022: $894 · 2023: $1,149 · 2024: $1,369 · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,377.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,082.70 | 2019-2025 | Spaceoar Vue System - 10ml, Axonics, Lumenis Pulse 120h |
| Coloplast Corp | $866.77 | 2019-2025 | Speedicath, Titan |
| Axonics, INC. | $851.42 | 2020-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $674.68 | 2019-2025 | Xtandi |
| Procept Biorobotics Corporation | $515.86 | 2019-2024 | Aquabeam System, Aquabeam Robotic System |
| Myriad Genetic Laboratories, INC. | $337.52 | 2023-2024 | Prolaris |
| Teleflex LLC | $234.22 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $231.67 | 2023-2025 | Orgovyx, Gemtesa |
| Endo Pharmaceuticals INC. | $217.00 | 2019-2023 | Xiaflex |
| Janssen Biotech, INC. | $215.93 | 2019-2025 | Erleada, Akeega |
| Neotract INC. | $199.96 | 2019-2020 | |
| Abbvie INC. | $155.50 | 2019-2025 | |
| Myovant Sciences INC. | $136.53 | 2021-2022 | |
| Pfizer INC. | $134.45 | 2019-2025 | |
| Tolmar, INC. | $133.80 | 2023-2025 | Jatenzo, Eligard |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Muse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.